Chromosomal rearrangements are found in virtually all types of human cancers. We show that certain chromosome translocations display a delay in mitotic chromosome condensation that is associated with a delay in the mitosis-specific phosphorylation of histone H3. This delay in mitotic condensation is preceded by a delay in both the initiation as well as the completion of chromosome replication. In addition, chromosomes with this phenotype participate in numerous secondary translocations and rearrangements. Chromosomes with this phenotype were detected in five of seven tumor-derived cell lines and in five of thirteen primary tumor samples. These data suggest that certain chromosomal rearrangements found in tumor cells cause a significant delay in replication timing of the entire chromosome that subsequently results in delayed mitotic chromosome condensation and ultimately in chromosomal instability.C ancer cells differ from their normal cellular counterparts in many important characteristics, including loss of differentiation, increased genomic instability, and decreased drug sensitivity. Not surprisingly, genetic alterations occur in most, if not all cancer cells, and are thought to lie at the heart of these phenotypic alterations. Furthermore, molecular analysis of individual tumors often reveals multiple genetic changes, including chromosomal translocations, deletions, insertions, gene amplifications, and point mutations. Recent surveys have identified more than 2,000 recurrent chromosomal aberrations among different neoplastic disorders (1, 2). However, the molecular and phenotypic alterations that are associated with the majority of these chromosomal changes remain undefined. The results described in this report characterize a new type of chromosomal abnormality that occurs with certain chromosome rearrangements, and is associated with abnormal chromosome replication timing, abnormal mitotic chromosome condensation, and considerable chromosomal instability.
MethodsCells. C2C12, CRL-5845, CRL-5824, HTB-81, HTB-118, WERI-RB1, and HELA cells were from the American Type Culture Collection. RH30 cells were provided by P. Houghton (St. Jude Children's Hospital, Memphis, TN). All cell lines were grown in DMEM supplemented with 10% FBS (HyClone). CRL-5845 and RH30 cells were stably transfected with pRSVNEO by electroporation (300 volts, 950 F in PBS; Bio-Rad), and Ϸ2,000 clones were pooled and expanded for use as donors in microcell fusions.Microcell Mediated Chromosome Transfer. Donor cells were micronucleated by adding 10.0 g of colcemid per ml in DMEM plus 15% calf serum for 48 h. The micronucleate cell populations were enucleated by centrifugation in the presence of 5 g of cytochalasin B (Sigma) per ml, and the isolated microcells were fused to C2C12 recipients as described (3, 4). Microcell hybrids were isolated by using cloning cylinders after 3-4 weeks of selection in medium containing 500 g of Geneticin (GIBCO) per ml.Fluorescent in Situ Hybridization. Chromosome preparations from primary tumors were harveste...